alpha(v)beta(3) Antagonists based on a central thiophene scaffold

A series of novel, highly potent alpha(v)beta(3) antagonists based on a thiophene scaffold and containing an acylguanidine as an Arg-mimetic is described. A number of structural features, such as cyclic versus open guanidine and a variety of lipophilic side chains, carbamates, sulfonamides and beta-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2001-08, Vol.11 (15), p.2011-2015
Hauptverfasser: Peyman, A, Scheunemann, K, Will, D W, Knolle, J, Wehner, V, Breipohl, G, Stilz, H U, Carniato, D, Ruxer, J, Gourvest, J, Auberval, M, Doucet, B, Baron, R, Gaillard, M, Gadek, T R, Bodary, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of novel, highly potent alpha(v)beta(3) antagonists based on a thiophene scaffold and containing an acylguanidine as an Arg-mimetic is described. A number of structural features, such as cyclic versus open guanidine and a variety of lipophilic side chains, carbamates, sulfonamides and beta-amino acids were explored with respect to inhibition of alpha(v)beta(3) mediated cell adhesion and selectivity versus alpha(IIb)beta(3) binding. In addition, compound 19 was found to be active in the TPTX model of osteoporosis.
ISSN:0960-894X
DOI:10.1016/S0960-894X(01)00357-2